Centro Hospitalar Universitario de Lisbona Central
- Address
- Rua Jose Ant Nio Serrana, Lisbon, Portugal
Centro Hospitalar Universitario de Lisboa Central - Cardiovascular and Cerebrovascular Research
Centro Hospitalar Universitario de Lisboa Central is actively engaged in advanced cardiovascular research, with particular expertise in managing complex cases involving stroke prevention and anticoagulation therapy. The center specializes in investigating treatment strategies for high-risk populations where standard therapeutic approaches present significant clinical challenges.
- Anticoagulation therapy in patients with atrial fibrillation and previous bleeding complications
- Stroke prevention strategies in high-risk cardiovascular populations
- Management of intracranial hemorrhage survivors requiring thromboembolism prophylaxis
The institution demonstrates particular strength in conducting trials evaluating novel approaches to atrial fibrillation management in patients with previous intracranial hemorrhage, a population traditionally excluded from anticoagulation studies. This research focuses on optimizing the balance between preventing ischemic stroke and systemic embolism while minimizing recurrent bleeding risks, addressing a critical unmet need in cardiovascular medicine for patients with CHA2DS2-VASc scores indicating high thromboembolic risk.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 84 other sites in Portugal
Therapeutic Area Benchmark — Portugal
Select a therapeutic area to compare against other sites in Portugal.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Portugal
Market Share
Country: Portugal
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro Hospitalar Universitario de Lisbona Central
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Edoxaban Versus Nonanticoagulant Therapy in High-Risk Atrial Fibrillation Patients with Prior Intracranial Hemorrhage | Hamilton Health Sciences Corporation, PHRI Population Health Research Institute International | Phase III | Not Recruiting | Dec 2024 | Jul 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Edoxaban | 1 | Unknown | 2024-12-09 | 2024-12-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.